Sugentech Inc Asset Resilience Ratio

Latest as of June 2026: 21.51%

Sugentech Inc asset resilience ratio. Sugentech Inc (253840) has an Asset Resilience Ratio of 21.51% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 253840 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩18.78 Billion
≈ $12.72 Million USD Cash + Short-term Investments

Total Assets

₩87.28 Billion
≈ $59.15 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio of Sugentech Inc (2017–2025)

Asset resilience ratio of Sugentech Inc from 2017 to 2025. This chart shows how Sugentech Inc's Asset Resilience Ratio has changed over time. Read Sugentech Inc total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Sugentech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 253840 total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩18.78 Billion 21.51%
Total Liquid Assets ₩18.78 Billion 21.51%

Asset Resilience Insights

  • Good Liquidity Position: Sugentech Inc maintains a healthy 21.51% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Sugentech Inc Industry Peers by Asset Resilience Ratio

Compare Sugentech Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Applied BioCode
TW:6598
Medical Devices 9.75%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%
Cleo Diagnostics Ltd
AU:COV
Medical Devices 94.64%
Radiant Innovation
TWO:3373
Medical Devices 0.82%
Impedimed Ltd
AU:IPD
Medical Devices 46.15%
Memphasys Ltd
AU:MEM
Medical Devices 0.00%

Sugentech Inc Asset Resilience Ratio by Year (2017–2025)

Sugentech Inc asset resilience ratio by year from 2017 to 2025. The table below shows the annual Asset Resilience Ratio data for Sugentech Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 25.25% ₩24.80 Billion
≈ $16.81 Million
₩98.21 Billion
≈ $66.56 Million
-24.49pp
2024-12-31 49.75% ₩53.55 Billion
≈ $36.29 Million
₩107.64 Billion
≈ $72.95 Million
-0.32pp
2023-12-31 50.07% ₩66.68 Billion
≈ $45.19 Million
₩133.19 Billion
≈ $90.26 Million
-13.34pp
2022-12-31 63.40% ₩109.87 Billion
≈ $74.46 Million
₩173.30 Billion
≈ $117.44 Million
-6.24pp
2021-12-31 69.64% ₩108.34 Billion
≈ $73.42 Million
₩155.56 Billion
≈ $105.42 Million
+20.59pp
2020-12-31 49.06% ₩35.54 Billion
≈ $24.09 Million
₩72.46 Billion
≈ $49.10 Million
-15.92pp
2019-12-31 64.97% ₩29.51 Billion
≈ $20.00 Million
₩45.42 Billion
≈ $30.78 Million
+29.53pp
2018-12-31 35.44% ₩8.64 Billion
≈ $5.85 Million
₩24.37 Billion
≈ $16.52 Million
+17.02pp
2017-12-31 18.42% ₩3.37 Billion
≈ $2.28 Million
₩18.28 Billion
≈ $12.39 Million
--
pp = percentage points

About Sugentech Inc

KQ:253840 Korea Medical Devices
Market Cap
$41.39 Million
₩61.08 Billion KRW
Market Cap Rank
#22401 Global
#1436 in Korea
Share Price
₩3995.00
Change (1 day)
+1.78%
52-Week Range
₩3620.00 - ₩7700.00
All Time High
₩53604.23
About

Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2… Read more